Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McMaster University

$17,500.00

Exploring the bioactivity of neuroprotective isoindolinones produced by the fruiting bodies of Hericium erinaceus

EF 2023-24

Résumé
Neurodegenerative diseases such as Alzheimer's and Parkinson's disease are an emerging public health concern with an estimated 50 million people worldwide currently affected. Without proper treatments and interventions, this number is expected to rise to almost 152 million in 2050. Thus, there is an immediate and unmet need for curative treatments of neurodegenerative diseases, with a focus on developing therapeutics that can reverse disease progression. Some of the top medications to treat Alzheimer's disease are either natural products or semi-synthetic derivatives, such as galantamine and rivastigmine. This highlights the value that natural products provide in drug development. Fungal natural products represent an untapped reservoir of bioactive compounds which can inspire novel drug scaffolds. In the search for novel neurodegenrative treatments, fungal natural products are a treasure trove of opportunity. One such example is an edible and medicinal mushroom called Hericium erinaceus, the fruiting bodies of which produce a neuroprotective group of isoindolinone compounds, called the isohericerins. Recently, neuroprotective activity was observed in two natural analogs called N- de(phenylethyl) isohericerin and isohericerinol A. Such examples of neuroprotection provide a unique avenue for neurodegenerative treatments. The aim of this project is to further characterize the neuroactivity of these isoindolinone natural products from H. erinaceus and investigate their mechanism of action. Through techniques such as neurites assay, mammalian cells phenotypic profiling, Caenorhabditis elegans behavioral profiling, and medicinal chemistry we can investigate potential drugs to combat neurodegenerative diseases and investigate their mechanism of action.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
508868
Name
Kukje Zada Dima
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Exploring the bioactivity of neuroprotective isoindolinones produced by the fruiting bodies of Hericium erinaceus
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Analytical Chemisty; Biochemistry; Drug Discovery; Medicinal Chemistry; Mycology; N/A; Natural Products; Neuroactive Compounds
Abstract
Neurodegenerative diseases such as Alzheimer's and Parkinson's disease are an emerging public health concern with an estimated 50 million people worldwide currently affected. Without proper treatments and interventions, this number is expected to rise to almost 152 million in 2050. Thus, there is an immediate and unmet need for curative treatments of neurodegenerative diseases, with a focus on developing therapeutics that can reverse disease progression. Some of the top medications to treat Alzheimer's disease are either natural products or semi-synthetic derivatives, such as galantamine and rivastigmine. This highlights the value that natural products provide in drug development. Fungal natural products represent an untapped reservoir of bioactive compounds which can inspire novel drug scaffolds. In the search for novel neurodegenrative treatments, fungal natural products are a treasure trove of opportunity. One such example is an edible and medicinal mushroom called Hericium erinaceus, the fruiting bodies of which produce a neuroprotective group of isoindolinone compounds, called the isohericerins. Recently, neuroprotective activity was observed in two natural analogs called N- de(phenylethyl) isohericerin and isohericerinol A. Such examples of neuroprotection provide a unique avenue for neurodegenerative treatments. The aim of this project is to further characterize the neuroactivity of these isoindolinone natural products from H. erinaceus and investigate their mechanism of action. Through techniques such as neurites assay, mammalian cells phenotypic profiling, Caenorhabditis elegans behavioral profiling, and medicinal chemistry we can investigate potential drugs to combat neurodegenerative diseases and investigate their mechanism of action.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kukje Zada, Dima
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~